Generic placeholder image

Applied Drug Research, Clinical Trials and Regulatory Affairs

Editor-in-Chief

ISSN (Print): 2667-3371
ISSN (Online): 2667-338X

Perspective

Navigating the Regulatory Maze: The Vital Role of Regulatory Affairs in Pharmaceutical Safety and Quality

Author(s): Sankushdeep Singh, Ankit Dahiya, Subhi Sharma, Ankit Awasthi and Shubham Thakur*

Volume 10, 2024

Published on: 22 September, 2024

Article ID: e26673371327363 Pages: 5

DOI: 10.2174/0126673371327363240911071617

TIMBC 2025
[1]
Unissa M. The role of regulatory affairs in the pharmaceutical industries: A review. J Pharm Res Technol 2023; 1(1): 1-7.
[2]
Kumar S, Panwar R, Singh U. Regulatory affairs in the pharmacy curriculum. Int J Res Develop Pharm Life Sci 2013; 2(6): 690-8.
[3]
Rao NR, Tiwari A, Pal A, Pathak A, Maurya A, Ali I. Overview of drug regulatory affairs and role of regulatory affairs in a pharmaceutical industry. Pak Heart J 2023; 56(2): 986-98.
[4]
Roshan K, Aayush J. Role of regulatory affairs in pharmaceutical company: An overview. Glob J Res Anal 2018; 7(1): 2277-8160.
[5]
Badhe P, Wagh T, Shirapure K. A review on the role of regulatory affairs in the pharmaceutical industry.
[6]
Janjal VS, Dhamodkar SR, Jadhao YP, Manmode SB, Pawar AK, Khandelwal HR. Recent drug regulatory affair and CTD module progress review for submission of pharmaceuticals product. GSC Biol Pharm Sci 2021; 16(3): 200-21.
[http://dx.doi.org/10.30574/gscbps.2021.16.3.0279]
[7]
Chiodin D, Cox EM, Edmund AV, Kratz E, Lockwood SH. Regulatory affairs 101: introduction to investigational new drug applications and clinical trial applications. Clin Transl Sci 2019; 12(4): 334-42.
[http://dx.doi.org/10.1111/cts.12635] [PMID: 30884199]
[8]
Kumar BJ. Overview of drug regulatory affairs and regulatory profession. Int J Drug Regul Aff 2013; 1(1): 1-4.
[http://dx.doi.org/10.22270/ijdra.v1i1.1]
[9]
Lale S, Kendre A, Gandhi M, Dani S. Role of drug regulatory affairs in pharma industry. World J Pharm Res SJIF 2015; 4(6): 615-25.
[10]
Mahaparale S, Desai B. Role and overview of drug regulatory affairs in the pharmaceutical industry with implementation of CTD and ECTD. World J Pharm Res 2018.
[http://dx.doi.org/10.20959/wjpr20187-11267.]
[11]
Handoo S, Khera D, Nandi PK, Sahu SK, Arora V. A comprehensive study on regulatory requirements for development and filing of generic drugs globally. Int J Pharm Investig 2012; 2(3): 99-105.
[http://dx.doi.org/10.4103/2230-973X.104392] [PMID: 23373001]
[12]
Cordeiro MA, Vitorino C, Sinogas C, Sousa JJ. A Regulatory perspective on biosimilar medicines. Pharmaceutics 2024; 16(3): 321.
[http://dx.doi.org/10.3390/pharmaceutics16030321] [PMID: 38543215]
[13]
Arote KS, Salade DA, Patil NV. A brief review on regulatory affairs: ensuring compliance, safety, and market access. Int J Pharma Sci 2023; 1(9): 1.
[14]
Sanghi DK, Tiwle R. Role of regulatory affairs in a pharmaceutical industry. IJPRR 2014; 4(2): 127-31.

© 2025 Bentham Science Publishers | Privacy Policy